Discovering New Drugs For Ipf

Discovering New Drugs for IPF

The France Foundation

Uniting human and machine intelligence for drug discovery in IPF

Clinical Trials Innovation Series: Potential new treatments for pulmonary fibrosis

Pulmonary Fibrosis Foundation

New Drugs Give Glimmer Of Hope For IPF

Important IPF Clinical Trial Opportunity for New Antifibrotic Medication

New drug slows scaring of the lungs due to pulmonary fibrosis

IPFsym®, a platform to support the development of effective treatments for IPF patients

Simulations Plus, Inc.

Quality of Life with New IPF Medications

Finding treatments faster for patients with pulmonary fibrosis: an introduction to REMAP-ILD.

Action for Pulmonary Fibrosis

GB0139 (formerly TD139): A potential therapeutic for IPF?

Demystifying Medicine McMaster

The Importance of Early Referral and Treatment for IPF

The France Foundation

Pulmonary fibrosis clinical trials: Potential new treatments

Pulmonary Fibrosis Foundation

How AI Is Accelerating Drug Discovery

Insilico Medicine

Drug Development in IPF: What is on the Horizon I Andy Limper, MD

Pulmonary Fibrosis Foundation

NTU Hospital doctors find protein that causes idiopathic pulmonary fibrosis

民視英語新聞 Taiwan News Formosa TV

Dr Steven Nathan Discusses the 2 Newly Approved Drugs to Treat IPF

Doctors at KU Health System discover new cystic fibrosis drug treatment

FOX4 News Kansas City

Idiopathic pulmonary fibrosis: Medical research

Demystifying Medicine McMaster

Nuformix discusses its repurposed new drug targeting killer disease IPF

Proactive Investors

Breaking the Chains of Pulmonary Fibrosis: Dr. Hagood's Journey to a Cure

University Hospitals